Amidate(tm) Etomidate
Product Images NDC 51662-1455

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amidate(tm) Etomidate (NDC 51662-1455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How Supplied (How Supplied)

A data table listing units of sale and their respective concentrations for a pharmaceutical product. It includes three NDCs with packaging details: trays of 10 Flitop vials at 20 mg/10 mL and 40 mg/20 mL, and a bundle of 10 Abboject syringes with 20 mL capacity, all with a concentration of 2 mg/mL.*

FDA Label Image

Logo (Logo)

FDA Label Image

Seerialized Labeling (Serialized Labeling)

AMIDATE Etomidate Injection USP 40 mg/20 mL (2 mg/mL) clear solution in a 20 mL single-dose fliptap vial with a blue cap. Label shows the active ingredient etomidate, along with instructions for intravenous use only. Distributed by HF Acquisition Co LLC DBA HealthFirst.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient Etomidate from AMIDATE(TM) ETOMIDATE. The diagram shows the molecular components and bonds, including a phenyl group and an imidazole ring.*

FDA Label Image

Vial Opt 1 (Vial Label Opt 1)

Label for Amidate Etomidate Injection USP 40 mg/20 mL (2 mg/mL) single-dose fliptop vial. The label states intravenous use only and includes the NDC 0409-6695-12. Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. Contains dosing and storage instructions, with a barcode on the right side.*

FDA Label Image

Vial Label Opt 2 (Vial Label Opt 2)

Label for Amidate Etomidate Injection, USP 40 mg/20 mL (2 mg/mL) in a 20 mL single-dose fliptop vial. The product is indicated for intravenous use only and contains etomidate 2 mg per mL with 35% propylene glycol as solvent. Labeler is Hospira, Inc., Lake Forest, IL 60045 USA.*

FDA Label Image

Vial Label Opt 3 (Vial Label Opt 3)

Label of Amidate (Etomidate Injection, USP) 40 mg/20 mL single-dose fliptop vial. The label indicates a concentration of 2 mg/mL etomidate, for intravenous use only, distributed by Hospira, Inc. It includes a National Drug Code (NDC 0409-6695-12) and notes the vial is sterile and nonpyrogenic.*

FDA Label Image

Vial Label Opt 4 (Vial Label Opt 4)

Label for Amidate etomidate injection, USP, 40 mg/20 mL (2 mg/mL) in a single-dose flip top vial. The label states intravenous use only, distributed by Hospira, Inc., Lake Forest, IL. It includes the NDC 0409-6695-12, lists etomidate 2 mg per mL with 35% propylene glycol, and notes sterility and nonpyrogenicity.*

FDA Label Image

Vial Label Opt 5 (Vial Label Opt 5)

Label for Amidate Etomidate Injection USP, 40 mg/20 mL (2 mg/mL) in a 20 mL single-dose fliptop vial. It is for intravenous use only. The label includes active ingredient etomidate, propylene glycol 35%, and instructions to discard unused portion. Distributed by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.